S, N., F, K., M, J., F, M., A, T., Z, B., . . . HG, P. (2025). Ferroptosis and cognitive impairment: Unraveling the link and potential therapeutic targets. Neuropharmacology, 263, 110210. https://doi.org/10.1016/j.neuropharm.2024.110210
Chicago Style (17th ed.) CitationS, Naderi, Khodagholi F, Janahmadi M, Motamedi F, Torabi A, Batool Z, Heydarabadi MF, and Pourbadie HG. "Ferroptosis and Cognitive Impairment: Unraveling the Link and Potential Therapeutic Targets." Neuropharmacology 263 (2025): 110210. https://doi.org/10.1016/j.neuropharm.2024.110210.
MLA (9th ed.) CitationS, Naderi, et al. "Ferroptosis and Cognitive Impairment: Unraveling the Link and Potential Therapeutic Targets." Neuropharmacology, vol. 263, 2025, p. 110210, https://doi.org/10.1016/j.neuropharm.2024.110210.